期刊文献+

苯磺贝他斯汀片的含量测定 被引量:3

Determination of Bepotastine Besilate Tablets by HPLC
暂未订购
导出
摘要 目的建立苯磺贝他斯汀片剂含量测定的方法。方法采用菲罗门Luna C8(250×4.65mm,5μm)为色谱柱,流动相为磷酸盐缓冲液(取磷酸二氢钾6.8g,加水1000m L使溶解,用磷酸调节pH值至3.0)-乙腈(70∶30),每1000m L流动相中含戊烷磺酸钠1.0g。流速为1.0m L·min^(-1),检测波长为260nm。结果苯磺贝他斯汀在48.1056~64.1408μg·m L^(-1)浓度范围内呈良好的线性相关(r=0.9998),平均回收率为99.67%,RSD为0.17%。结论本法准确可靠,可用于苯磺贝他斯汀片剂的质量控制。 OBJECTIVE To establish a method for determination of bepotastine besilate tablets by HPLC. METHODS HPLC was carried out on column of Luna Cs(250 ×4. 65mm,5μm). The mobile phase was a solution of sodium 1-pentanesulfonate in a mixture of 0. 05tool · L^-1 potassium dihydrogen phosphate TS, pH 3.0 and acetonitrile(7 : 3) (lg in 1000mL). The flow rate of 1.0mL · min^-1, and the detecting wavelength was at 260nm. RESULTS The linear range of bepotastine besilate was 48. 1056 - 64. 1408μg · mL^-1 (r = 0. 9998 ) and the average recovery was 99.67% ,RSD was 0. 17%. CONCLUSION This method is reliable and accurate for the quality control of bepotastine besilate tablets.
出处 《海峡药学》 2017年第5期38-40,共3页 Strait Pharmaceutical Journal
基金 福州市科技计划项目(2014-S-129) 福建省化药技术重大研发平台(No.2014Y2001) 福州市生物制药行业技术创新中心(No.2016-PT-36)
关键词 苯磺贝他斯汀片 HPLC 含量测定 Bepotastine besilate tablets HPLC Content determination
  • 相关文献

参考文献4

二级参考文献65

  • 1开月梅.变应性鼻炎(特异性)免疫治疗患者的依从性及相关因素调查[J].中国中西医结合耳鼻咽喉科杂志,2006,14(3):145-147. 被引量:11
  • 2赵志全,周宗仪,彭立增.苯磺酸贝他斯汀的不对称合成[J].中国医药工业杂志,2006,37(11):726-727. 被引量:10
  • 3王成硕,张罗,韩德民,王向东,赵岩,周兵,刘健慧.标准化尘螨变应原疫苗治疗变应性鼻炎一年的疗效和安全性研[J].中国耳鼻咽喉头颈外科,2007,14(1):3-6. 被引量:62
  • 4Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its hn- pact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA ( 2 ) LEN and AllerGen ) [ J ]. Aller- gy,2008,63 ( Suppl 86 ) : 8-1 60.
  • 5Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary [ J ]. Euro Respir J, 2008,31 ( 1 ) : 143-178.
  • 6Nelson HS. Muhiallergen immunotherapy for allergic rhinitis and asthma[ J] . Allergy Clin Immunol, 2009, 123 (4) : 763-769.
  • 7Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe [ J ]. Ann Allergy Asthma Immunol,2009,103 (6) :451-459.
  • 8Pipet A, Botturi K, Pinot D, et al. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy [ J ]. Respir Med,2009,103 (6) : 800-812.
  • 9Ciprandi G, Cadario G, Di Gioacehino GM, et al. Sublingual immu- notherapy in children with allergic polysensitization [ J ]. AllergyAsthma Proc, 2010,31 ( 3 ) : 227 -231.
  • 10Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects[ J]. J Allergy Clin Immunol, 1993,91 ( 3 ) :709-722.

共引文献43

同被引文献11

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部